News
8h
HealthDay on MSNADHD Medications Remain Linked to Lower Risk for Real-World Adverse OutcomesAttention-deficit/hyperactivity disorder (ADHD) medications remain associated with a reduced risk for various real-world ...
Discover a study that explores how a personalised mHealth exercise program can effectively improve ADHD symptoms in children.
The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...
Many with ADHD grieve a life they feel they’ve missed. Healing begins by naming it—and choosing a new way forward.
11h
Health and Me on MSNFDA Mandates ADHD Drug Labels To Warn Of Weight Loss RiskThe FDA now requires ADHD extended-release drug labels to warn of weight loss risks in children under 6, urging monitoring ...
The U.S. Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants used to ...
21h
PsyPost on MSNCreativity in autism may stem from co-occurring ADHD, not autism itselfIs creativity really a strength of autism? A new study says not necessarily. When controlling for ADHD and cognitive ability, ...
A major Swedish study of 247,420 individuals with attention-deficit/hyperactivity disorder (ADHD) has found that medication ...
Labels of all extended-release stimulants indicated for ADHD -- including certain formulations of amphetamine and ...
Figures suggest adults with ADHD are five times more likely to try to take their own lives than those without it. | ITV News ...
The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...
The Food and Drug Administration is revising the labeling of all extended-release stimulants used to treat attention-deficit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results